Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma

ABSTRACT: Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma

PROVIDER: PRJNA753288 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15402148.fastq.gz	Fastqsanger.gz
	SRR15402149.fastq.gz	Fastqsanger.gz
	SRR15402150_1.fastq.gz	Fastqsanger.gz
	SRR15402150_2.fastq.gz	Fastqsanger.gz
	SRR15402151_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [lncRNA-seq]

Project description:Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [lncRNA-seq]

| PRJNA753297 | ENA

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [ChIP-seq]

Project description:Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [ChIP-seq]

| PRJNA753296 | ENA

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [ChIP-seq]

Project description:Super-enhancer (SE) plays a vital role in the determination of cell identity and cell fate through the control of cell- or tissue-specific gene regulation. Upregulated expression of coding genes is frequently associated with SE. However, the transcription dysregulation driven by SE, from long non-coding RNAs (lncRNAs) viewpoint, remains unclear. Here, SE-associated lncRNAs in HCC were comprehensively screened.

2024-08-07 | GSE181753 | GEO

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma [lncRNA-seq]

2024-08-07 | GSE181754 | GEO

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Project description:Here we apply integrated epigenomic and transcriptomic profiling to uncover super-enhancer heterogeneity between breast cancer subtypes, and provide clinically relevant biological insights towards TNBC. Using CRISPR/Cas9-mediated gene editing, we identify genes that are specifically regulated by TNBC-specific super-enhancers, including FOXC1 and MET, thereby unveiling a mechanism for specific overexpression of the key oncogenes in TNBC. We also identify ANLN as a novel TNBC-specific gene regulated by super-enhancer. Our studies reveal a TNBC-specific epigenomic landscape, contributing to the dysregulated oncogene expression in breast tumorigenesis.

2021-03-04 | PXD024505 |

Enhancer and super-enhancer landscape in ADPKD

Project description:Enhancer and super-enhancer landscape in ADPKD

| PRJNA836927 | ENA

enhancer and super-enhancer landscape in ADPKD

Project description:enhancer and super-enhancer landscape in ADPKD

| PRJNA781663 | ENA

eRNAs and super-enhancer lncRNAs are functional in human prostate cancer

Project description:Prostate cancer (PCa) is one of the most commonly diagnosed cancers in males worldwide. lncRNAs (long non-coding RNAs) play a significant role in the occurrence and development of PCa. eRNAs (enhancer RNA) and SE-lncRNAs (super-enhancer lncRNA) are important elements of lncRNAs, but the role of eRNAs and SE-lncRNAs in PCa remains largely unclear. In this work, we identified 681 eRNAs and 292 SE-lncRNAs that were expressed differentially in PCa using a microarray. We constructed a transcriptional regulation network that eRNA related enhancer and the target genes shared the same TF binding motifs. Further, we investigated whether CTCF played a role in mediating the transcriptional regulation network. eRNAs, especially those that regulate androgen response genes, may be candidates for prognostic biomarkers and therapy targets. Our work provide a new perspective for developing medical treatments and therapies for prostate cancer.

2020-10-13 | GSE155056 | GEO

Landscape of super-enhancer-associated lncRNAs in hepatocellular carcinoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-08-07 | GSE181755 | GEO

Super-enhancer landscape profiling in primary colorectal carcinoma

Project description:Purpose: Examine H3K27ac enhancer and super-enhancer landscape differences between primary colorectal carcinoma and adjacent normal mucosa towards the identification of novel downstream targets. Methods: H3K27ac ChIP-seq and RNA-seq were performed on fresh primary colorectal carcinoma samples and normal colonic mucosa, from human patient samples. Results: We identified 2026 total super-enhancers in our cohort, between primary colorectal and normal mucosa. We quantified differences in H3K27ac signal within this space, between tumor and normal, and identified putative downstream target genes through integration with sample matched RNA-seq using a positive linear correlation model to identifty putative target genes.

2022-08-03 | GSE166254 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data